Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for Its Targeting for Treatment

International Journal of Molecular Sciences - Switzerland
doi 10.3390/ijms19082299
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Inflammatory and Fibrotic Mediators in Renal Diseases

Mediators of Inflammation
ImmunologyCell Biology
2019English

Anti-Inflammatory MicroRNAs and Their Potential for Inflammatory Diseases Treatment

Frontiers in Immunology
AllergyImmunology
2018English

Antioxidant Nanotherapies for the Treatment of Inflammatory Diseases

Frontiers in Bioengineering and Biotechnology
BioengineeringBiomedical EngineeringHistologyBiotechnology
2020English

COVID-19: Risk for Cytokine Targeting in Chronic Inflammatory Diseases?

Nature Reviews Immunology
MedicineAllergyImmunology
2020English

Are Mast Cells Instrumental for Fibrotic Diseases?

Frontiers in Pharmacology
Pharmacology
2014English

Targeting Treg Signaling for the Treatment of Autoimmune Diseases

Current Opinion in Immunology
AllergyImmunology
2015English

Catestatin as a Target for Treatment of Inflammatory Diseases

Frontiers in Immunology
AllergyImmunology
2018English

Omics Technologies and the Choice of Treatment Strategy for Inflammatory Intestinal Diseases

Dokazatel'naya gastroenterologiya
2018English

Targeting Leukocyte Trafficking for the Treatment of Inflammatory Bowel Disease

Clinical Pharmacology and Therapeutics
Pharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy